Empresa Pacific Biosciences of California, Inc.
Acciones
PACB
US69404D1081
Equipo médico y tecnología avanzada
Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
1,47 USD | +6,52 % | -5,16 % | -85,02 % |
23/04 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. : JPMorgan Chase es neutral | ZM |
18/04 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. : Scotiabank da una recomendación de compra | ZM |
Resumen de negocios
Número de empleados: 796
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Instrument
60,1
%
| 49 | 38,0 % | 120 | 60,1 % | +147,24 % |
Consumable
31,6
%
| 60 | 46,7 % | 63 | 31,6 % | +5,74 % |
Service and Other
8,3
%
| 20 | 15,3 % | 17 | 8,3 % | -15,08 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Americas
52,6
%
| 70 | 54,2 % | 105 | 52,6 % | +51,54 % |
Asia-Pacific
27,2
%
| 36 | 28,2 % | 54 | 27,2 % | +50,65 % |
Europe, Middle East, and Africa
20,3
%
| 23 | 17,6 % | 41 | 20,3 % | +79,92 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Stephen Turner
FOU | Founder | 56 | 14/07/00 |
Christian Henry
CEO | Chief Executive Officer | 56 | 01/08/18 |
Susan Kim
DFI | Director of Finance/CFO | 48 | 28/09/20 |
Mark van Oene
COO | Chief Operating Officer | 51 | 08/01/21 |
Jonas Korlach
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/04 |
Kathy Ordoñez
BRD | Director/Board Member | 73 | 17/12/14 |
Todd Friedman
IRC | Investor Relations Contact | - | - |
Mike Goloubef
PRN | Corporate Officer/Principal | - | 01/01/20 |
Natalie Welch
HRO | Human Resources Officer | - | 01/10/08 |
Neil Ward
PRN | Corporate Officer/Principal | - | 08/06/21 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
John Milligan
CHM | Chairman | 63 | 18/07/13 |
Marshall Mohr
BRD | Director/Board Member | 67 | 18/01/12 |
Christian Henry
CEO | Chief Executive Officer | 56 | 01/08/18 |
Director/Board Member | 70 | 01/01/09 | |
Lucy Shapiro
BRD | Director/Board Member | 83 | 12/09/12 |
Bill Ericson
BRD | Director/Board Member | 65 | 01/01/04 |
Kathy Ordoñez
BRD | Director/Board Member | 73 | 17/12/14 |
David Meline
BRD | Director/Board Member | 66 | 13/10/23 |
Hannah Valantine
BRD | Director/Board Member | 72 | 16/06/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 267 951 880 | 260 406 548 ( 97,18 %) | 0 | 97,18 % |
Información de la empresa
Pacific Biosciences of California, Inc.
1305 O'Brien Drive
94025, Menlo Park
+650 521 8000
http://www.pacb.comSector
Ventas por actividad
Ventas por región
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-85,02 % | 400 M | |
+8,07 % | 219 mil M | |
+6,59 % | 183 mil M | |
+11,26 % | 133 mil M | |
+26,57 % | 108 mil M | |
+13,35 % | 52,02 mil M | |
-0,62 % | 48,2 mil M | |
-0,93 % | 40,37 mil M | |
+11,54 % | 39,35 mil M | |
+26,76 % | 32,03 mil M |
- Bolsa de valores
- Acciones
- Acción PACB
- Empresa Pacific Biosciences of California, Inc.